Improving compliance with glaucoma eye-drop treatment

Article Abstract:

Nurses can play a key role in supporting patients with glaucoma, many of whom may be anxious about their condition. In particular, giving appropriate support can be crucial in improving patient compliance with eye-drop treatment for glaucoma. The nurse must develop a trusting relationship with the patient, who will then feel more able to talk about any problems with using the drops. It has also been found that compliance levels can be improved if drop instillation is taught carefully.

Practice, Nursing

---

Beta blocker eye drops

Article Abstract:

Beta blocker eye drops are used in the treatment of glaucoma and are effective at reducing intraocular pressure by reducing the rate of aqueous humour output. These drops should not be used in patients suffering from asthma as they cause many side effects, patients should be advised on the correct application of their drops and patients who use contact lenses should check whether their lenses are compatible with the formulation of eye drops.

Usage, Complications and side effects, Ophthalmic solutions

---

Glaucoma

Article Abstract:

Glaucoma is the name for a group of eye conditions affecting vision, where the two main types are open angle and acute angle closure. The symptoms include sore eyeball, red eye and opaque vision and halos when staring at light sources, and enlarged pupil.

Diagnosis, Eye diseases

Similar abstracts:

• Abstracts: Moving closer. Colorectal cancer: diagnosis and treatment
• Abstracts: Advances in care of premature babies create ethical dilemmas. Using guidelines to minimize the hazards of blood transfusion
• Abstracts: Improving primary care services for people with learning disability. Jane Warner a voice from primary care
• Abstracts: Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
• Abstracts: Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. Detection of bladder cancer using a point-of-care proteomic assay

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.